If you invest mainly in Indian equities, Screener.in is still the obvious choice.
This page only matters if your market world now extends beyond India.
Written by the CompoundPulse team · Last updated April 2, 2026
Screener.in is not missing the point. It is built for a narrower job. That focus is a strength until your own workflow stops being narrow too.
Screener.in has built the most trusted fundamental screening tool for India's equity markets. Its users are there for a reason: deep financial history for NSE and BSE-listed companies, custom ratio formulas, promoter and shareholder tracking, and a screener that understands the specific data points Indian investors care about. If India is the whole job, Screener.in is still the right tool.
This page does not argue otherwise.
The question is whether your workflow is still India-first enough for that to be enough. Because the moment your process now includes U.S. stocks, global macro orientation, crypto, forex, or cross-asset analysis, Screener.in stops being the whole workflow and starts being the India tab in it.
CompoundPulse does not replace Screener.in for Indian fundamentals. It becomes relevant when India is no longer the only market you need to think about in the same session.
Screener.in is the standard tool for Indian equity fundamental research. Ten-plus years of financial history, promoter shareholding patterns, pledge data, custom formula screeners — these are not features CompoundPulse has. If NSE/BSE fundamental analysis is your primary process, Screener.in is still the right tool for exactly that job.
Indian investors often care deeply about promoter holding trends, pledge ratios, and shareholder structure changes — context that is India-specific and not available in global platforms. Screener.in surfaces this natively. CompoundPulse does not include NSE/BSE market data.
Screener.in allows users to build custom financial ratios using Indian accounting data. For investors who have built proprietary screens around Indian-specific metrics, that is a genuine switching cost worth acknowledging honestly.
Screener.in has no charting. No crypto. No forex. No global equities. No backtesting. No heatmap. No insider tracking. No economic calendar. For investors who stay entirely within Indian equities, these are not gaps — they are irrelevant.
For investors who also follow U.S. markets, hold Bitcoin alongside Indian stocks, want to understand global macro risk, or want to backtest a strategy before sizing in — Screener.in requires several other tools to fill those gaps. That is when the workflow becomes fragmented.
CompoundPulse covers the global side: U.S. equities (8,000+ stocks, 30+ screener filters), 36+ crypto pairs, 11+ forex pairs, commodity futures, professional charting with 121 indicators, a live canvas heatmap across 7 timeframes, no-code backtesting, and insider trading tracker. For investors who want the full picture across global markets in one platform — and use Screener.in for India — the two tools can work alongside each other.
Screener.in (Premium) vs CompoundPulse. Reviewed April 2026.
| Feature | Screener.in | CompoundPulse |
|---|---|---|
| Indian equity (NSE/BSE) screening | ✓ Best-in-class | ✗ |
| India financial history (10+ years) | ✓ | ✗ |
| Custom ratio formulas | ✓ | ✗ |
| Promoter/shareholder data | ✓ | ✗ |
| Global equities (U.S. 8,000+ stocks) | ✗ | ✓ |
| Professional charting (121 indicators) | ✗ | ✓ |
| Live heatmap (500+ stocks, 7 timeframes) | ✗ | ✓ |
| No-code backtesting | ✗ | ✓ |
| Insider trading tracker | ✗ | ✓ |
| Options flow (real volume, IV, unusual activity) | ✗ | ✓ Live data |
| Crypto coverage (36+ pairs) | ✗ | ✓ |
| Forex coverage (30+ pairs) | ✗ | ✓ |
| Economic calendar | ✗ | ✓ FOMC, CPI, NFP |
| Asset correlation matrix | ✗ | ✓ |
| Paper trading simulator | ✗ | ✓ |
| Free access | ✓ Free tier | ✓ Free tier + 7-day premium trial |
If India is the whole job, stay with Screener.in. If India is now one part of a broader market workflow, that is where CompoundPulse starts to matter.
Screener.in is not missing the point. It is focused. The question is whether your workflow still is.
For NSE and BSE fundamental analysis specifically, yes. Screener.in has deep India-specific financial history and tools optimized for Indian markets. CompoundPulse does not include NSE/BSE data.
No. CompoundPulse includes professional charting with 121 indicators for all supported markets.
No. Screener.in covers Indian equities only. CompoundPulse covers 36+ crypto pairs, 11+ forex pairs, and commodity futures.
Yes — and many investors do. Screener.in for India-specific equity research, CompoundPulse for global equities, crypto, forex, charting, heatmap, and multi-asset analysis.
No. CompoundPulse focuses on global equities (primarily U.S. markets), crypto, forex, and futures. For Indian equity screening, Screener.in remains the dedicated tool.
Free tier available, no credit card. Full premium access for 7 days.
Start Free →Free tier always available · No credit card required